已收录 272962 条政策
 政策提纲
  • 暂无提纲
Dissolution Enhancement of Raltegravir by Hot Melt Extrusion Technique
[摘要] The objective of the study to develop an amorphous solid dispersion for poorly soluble raltegravir by hot melt extrusion (HME) technique. A novel solubility improving agent plasdone s630 was utilized. The HME raltegravir was formulated into tablet by direct compression method. The prepared tablets were assessed for all pre and post-compression parameters. The drug- excipients interaction was examined by FTIR and DSC. All formulas displayed complying with pharmacopoeial measures. The study reveals that formula prepared by utilizing drug and plasdone S630 at 1:1.5 proportion and span 20 at concentration about 30mg (trail-6) has given highest dissolution rate than contrasted with various formulas of raltegravir.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 计算机网络和通讯
[关键词] Hot melt extrusion;Raltegravir;Plasdone S630. [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文